The deal range was $14.50-$15.50. BofA, Citi, Piper Sandler, Cantor Fitzgerald and Truist acted as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CPRX:
- Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
- Salesforce upgraded, Chipotle downgraded: Wall Street’s top analyst calls
- Catalyst Pharmaceuticals initiated with an Outperform at Oppenheimer
- Catalyst Pharmaceuticals announces submission of FIRDAPSE NDA in Japan
- Catalyst Pharmaceuticals Announces FIRDAPSE® New Drug Application Submitted in Japan by Partner DyDo Pharma
